Compare AU

Compare JRHG vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

Jpmorgan Gl Re En In Eqh Active ETF (Managed Fund)

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are JRHG and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

JRHG

CURE

Popularity

N/A

Low

Pearlers invested

0

83

Median incremental investment

$0

$619.50

Median investment frequency

N/A

Monthly

Median total investment

$0

$1,461.60

Average age group

N/A

> 35


Key Summary

JRHG

CURE

Strategy

JRHG.AX was created on 2023-11-16 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity.

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

Jpmorgan Gl Re En In Eqh Active ETF (Managed Fund) (100 %)

Natera Inc (3.33 %)

Incyte Corp (2.95 %)

Gilead Sciences Inc (2.81 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.3 %

0.45 %


Key Summary

JRHG

CURE

Issuer

JPMorgan

Global X

Tracking index

MSCI World ex Australia - AUD - Benchmark TR Net Hedged

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.3 %

0.45 %

Price

$65.17

$52.00

Size

N/A

$36.301 million

10Y return

N/A

N/A

Annual dividend/ distribution yield (5Y)

0.14 %

4.24 %

Market

ASX

ASX

First listed date

15/11/2023

12/11/2018

Purchase fee

$6.50

$6.50


Community Stats

JRHG

CURE

Popularity

N/A

Low

Pearlers invested

0

83

Median incremental investment

$0

$619.50

Median investment frequency

N/A

Monthly

Median total investment

$0

$1,461.60

Average age group

N/A

> 35


Pros and Cons

JRHG

CURE

Pros

  • Lower management fee

  • Higher price growth

  • Higher exposure to US market

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Lower distribution yield

  • Higher management fee

  • Lower price growth

JRHG

CURE

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Lower distribution yield

Higher distribution yield

Home